上海药物所最新文章解析疾病机理-国内聚焦-资讯-生物在线

上海药物所最新文章解析疾病机理

作者:上海研吉生物科技有限公司 2011-06-24T00:00 (访问量:1491)

来自中科院上海生科院,上海药物所的研究人员取得了马兜铃酸肾毒性机制研究的新进展,这为深入研究马兜铃酸肾病(aristolochic acid nephropathy, AAN) 的致病机理,以及预防马兜铃酸肾病提供了重要资料。这一研究成果公布在毒理学领域颇具影响力的杂志《Toxicol Sci》上。

文章的通讯作者是上海药物研究所任进研究员和宫丽崑副研究员,其研究组主要研究方向是利用先进技术筛选安全的新型药物,以及建立标准药物安全评估系统。

马兜铃酸(AA)是马兜铃酸肾病(aristolochic acid nephropathy, AAN) 和巴尔干地方性肾病(Balkan endemic nephropathy, BEN)的致病原因,已经引起了国际上的高度重视。氧化和还原是AAI(AA的主要毒性成分)在不同物种体内快速清除必不可少的代谢过程。然而哪些酶参与AAI体内的氧化、还原代谢以及此代谢过程在AAI肾毒性中的作用尚不明确。

上海药物所药物安全评价中心前期的研究工作表明肝脏CYP1A参与AAI的氧化代谢,此代谢过程使小鼠血液及肾脏中AAI的含量降低继而减轻AAI所致的肾毒性。该研究结果已在Kidney Int(2008,73:1231-1239)杂志上发表。

肾脏不仅是还原代谢AAI能力最强的器官,也是AAI毒性的靶器官。因此研究人员在前期研究工作的基础上进一步探索了哪种酶参与肾脏AAI的还原代谢以及此代谢过程对AAI肾毒性的影响。结果显示NAD(P)H:醌氧化还原酶(NQO1)在肾脏具有较高的活性,且分布位置与AAI所致肾脏病变的部位一致。

NQO1的抑制剂双香豆素、苯茚二酮均可抑制AAI在肾脏内的还原代谢,延缓AAI的血浆清除。虽然抑制剂处理后,小鼠血液和肾脏中AAI的含量明显升高,但其所致肾毒性却显著降低,表明NQO1参与AAI在肾脏内的还原代谢,且这一还原代谢过程可能是AAI诱发肾脏毒性的主要原因。这一结果为深入研究AAN机理提供了新的依据、为马兜铃酸肾病预防提供了新的线索,同时也为中药安全性研究提供了新的思路。

原文摘要:

Inhibition of renal NQO1 activity by dicoumarol suppresses nitroreduction of aristolochic acid I and attenuates its nephrotoxicity.

Aristolochic acid I (AAI) is the major toxic component of aristolochic acid (AA), which causes aristolochic acid nephropathy (AAN) and Balkan endemic nephropathy (BEN). Nitroreduction is an essential metabolic process for AAI rapid clearance in different species including human. However, which enzyme participates in AAI nitroreduction in vivo and whether this metabolic process contributes to AAI nephrotoxicity are unclear. Here, we showed that NAD(P)H:quinone oxidoreductase 1 (NQO1) was highly expressed in mouse renal tubular epithelial cells. Inhibition of NQO1 activity by dicoumarol pretreatment significantly decreased renal aristolactam I (ALI) levels, a major reductive metabolite of AAI, while increased renal AAI and its major oxidative metabolite 8-hydroxy-aristolochic acid I (AAIa) levels in male C57BL/6 mice. Similar changes in renal ALI, AAI and AAIa levels were also observed in mice pretreated with another NQO1 inhibitor, phenindione. Consistent with higher levels of renal AAI and AAIa found in dicoumarol-pretreated mice, their serum clearance was much slower compared with vehicle-pretreated mice. The survival rate of mice pretreated with dicoumarol was markedly increased when higher doses of AAI were given. Similarly, pretreatment of mice with phenindione also attenuated AAI-induced nephrotoxicity. These results indicate that NQO1 plays an important role in renal AAI nitroreduction and may thus contribute to AAI-induced nephrotoxicity.

来源:生物通

上海研吉生物科技有限公司 商家主页

地 址: 上海市杨浦区民京路658弄

联系人: 陈小姐

电 话: 15821625591

传 真:

Email:muzhou88@aliyun.com

相关咨询
ADVERTISEMENT